DE60140120D1 - Toxizitätstypisierung unter verwendung von leberstammzellen - Google Patents

Toxizitätstypisierung unter verwendung von leberstammzellen

Info

Publication number
DE60140120D1
DE60140120D1 DE60140120T DE60140120T DE60140120D1 DE 60140120 D1 DE60140120 D1 DE 60140120D1 DE 60140120 T DE60140120 T DE 60140120T DE 60140120 T DE60140120 T DE 60140120T DE 60140120 D1 DE60140120 D1 DE 60140120D1
Authority
DE
Germany
Prior art keywords
toxicity
chemical compositions
typing
toxicities
molecular profiles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60140120T
Other languages
English (en)
Inventor
H Ralph Snodgrass
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vistagen Inc
Original Assignee
Vistagen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vistagen Inc filed Critical Vistagen Inc
Application granted granted Critical
Publication of DE60140120D1 publication Critical patent/DE60140120D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
DE60140120T 2000-06-14 2001-06-14 Toxizitätstypisierung unter verwendung von leberstammzellen Expired - Lifetime DE60140120D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21160600P 2000-06-14 2000-06-14
PCT/US2001/019187 WO2001096866A1 (en) 2000-06-14 2001-06-14 Toxicity typing using liver stem cells

Publications (1)

Publication Number Publication Date
DE60140120D1 true DE60140120D1 (de) 2009-11-19

Family

ID=22787620

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60140120T Expired - Lifetime DE60140120D1 (de) 2000-06-14 2001-06-14 Toxizitätstypisierung unter verwendung von leberstammzellen

Country Status (12)

Country Link
US (3) US20020012905A1 (de)
EP (1) EP1290444B1 (de)
JP (1) JP2004503256A (de)
KR (1) KR100865664B1 (de)
AT (1) ATE445158T1 (de)
AU (1) AU2001268449A1 (de)
CA (1) CA2412361C (de)
DE (1) DE60140120D1 (de)
DK (1) DK1290444T3 (de)
ES (1) ES2334639T3 (de)
HK (1) HK1054980A1 (de)
WO (1) WO2001096866A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7555492B2 (en) * 1999-11-05 2009-06-30 The Board Of Trustees At The Leland Stanford Junior University System and method for internet-accessible tools and knowledge base for protocol design, metadata capture and laboratory experiment management
AU2001268449A1 (en) 2000-06-14 2001-12-24 Vistagen, Inc. Toxicity typing using liver stem cells
US20050060102A1 (en) * 2000-10-12 2005-03-17 O'reilly David J. Interactive correlation of compound information and genomic information
EP1476747A4 (de) * 2002-01-31 2008-06-11 Ocimum Biosolutions Inc Molekulare hepatotoxikologiemodellierung
AU2003219713A1 (en) * 2002-02-04 2003-09-02 Gene Logic, Inc. Primary rat hepatocyte toxicity modeling
CA2484549A1 (en) * 2002-05-10 2003-11-20 Phase-1 Molecular Toxicology, Inc. Liver inflammation predictive genes
WO2004097585A2 (en) * 2003-04-24 2004-11-11 Stanford University System and method for internet-accessible tools and knowledge base for protocol design, metadata capture and laboratory experiment management
WO2005014793A2 (en) * 2003-08-07 2005-02-17 Gene Logic, Inc. Primary rat hepatocyte toxicity modeling
CA2546391A1 (en) * 2003-11-24 2005-06-09 Gene Logic, Inc. Methods for molecular toxicology modeling
AU2005212041A1 (en) * 2004-02-13 2005-08-25 Asahi Techno Glass Corporation Medium for preparing feeder cells for embryonic stem cells and feeder cells
WO2005124650A2 (en) * 2004-06-10 2005-12-29 Iconix Pharmaceuticals, Inc. Sufficient and necessary reagent sets for chemogenomic analysis
US7588892B2 (en) * 2004-07-19 2009-09-15 Entelos, Inc. Reagent sets and gene signatures for renal tubule injury
US20060040338A1 (en) * 2004-08-18 2006-02-23 Odyssey Thera, Inc. Pharmacological profiling of drugs with cell-based assays
US20060094059A1 (en) * 2004-09-22 2006-05-04 Odyssey Thera, Inc. Methods for identifying new drug leads and new therapeutic uses for known drugs
WO2006077981A1 (ja) * 2005-01-21 2006-07-27 Miyazaki Prefecture 高スループット機能性評価方法、プログラム、及び装置
JP4721752B2 (ja) * 2005-04-06 2011-07-13 独立行政法人科学技術振興機構 妊娠状態における薬物代謝予測法
US7795390B2 (en) 2005-06-24 2010-09-14 Teijin Pharma Limited Biological substance nesfatin and its related substances and uses thereof
AU2006292641B2 (en) 2005-09-20 2011-09-22 Micro Motion, Inc. Meter electronics and methods for generating a drive signal for a vibratory flowmeter
US20070198653A1 (en) * 2005-12-30 2007-08-23 Kurt Jarnagin Systems and methods for remote computer-based analysis of user-provided chemogenomic data
DK1966367T3 (da) * 2005-12-30 2010-05-03 Drugmode Aps Bioreaktor til celle- og vævskultur
US20100021885A1 (en) * 2006-09-18 2010-01-28 Mark Fielden Reagent sets and gene signatures for non-genotoxic hepatocarcinogenicity
JP2010505399A (ja) * 2006-10-02 2010-02-25 セルアーティス アーベー ヒト胚盤胞由来の幹細胞および前駆体細胞に基づく新規な毒性アッセイ
US8426807B2 (en) * 2008-08-01 2013-04-23 Brown University System and methods for determining molecules using mass spectrometry and related techniques
GB201103828D0 (en) * 2011-03-07 2011-04-20 Dundee Cell Products Ltd Evaluation of therapeutic agent
JP5820320B2 (ja) * 2012-03-27 2015-11-24 株式会社東芝 情報処理端末及び方法、並びに、情報管理装置及び方法
WO2016029211A1 (en) * 2014-08-22 2016-02-25 The General Hospital Corporation Systems and methods for discovery and characterization of neuroactive drugs
WO2016183231A1 (en) 2015-05-12 2016-11-17 Baker Group, LLP Method and system for a bioartificial organ
US10303757B2 (en) 2016-08-19 2019-05-28 Cognex Corporation Apparatuses, systems, and methods for providing a visual program for machine vision systems
KR102083408B1 (ko) * 2017-04-28 2020-03-02 가천대학교 산학협력단 줄기세포 기반의 독성 물질 스크리닝 방법
CN111549112A (zh) * 2020-04-02 2020-08-18 中国农业大学 一种丙烯酰胺暴露检测的标志物及其应用

Family Cites Families (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS191501B1 (en) 1976-04-02 1979-07-31 Richard Jelinek Method of testing the embryotoxicity on the chicken embryo
US4973493A (en) 1982-09-29 1990-11-27 Bio-Metric Systems, Inc. Method of improving the biocompatibility of solid surfaces
US5328695A (en) 1983-03-22 1994-07-12 Massachusetts Institute Of Technology Muscle morphogenic protein and use thereof
US5200313A (en) 1983-08-05 1993-04-06 Miles Inc. Nucleic acid hybridization assay employing detectable anti-hybrid antibodies
US4569774A (en) 1984-11-13 1986-02-11 Mobil Oil Corporation Polyglycol lubricants comprising trifluoromethane sulfonate
US6270961B1 (en) 1987-04-01 2001-08-07 Hyseq, Inc. Methods and apparatus for DNA sequencing and DNA identification
US5202231A (en) 1987-04-01 1993-04-13 Drmanac Radoje T Method of sequencing of genomes by hybridization of oligonucleotide probes
PT87133B (pt) 1987-04-02 1992-07-31 Amrad Corp Ltd Metodo de purificacao do factor inibidor da leucemia (lif) e de composicoes farmaceuticas contendo polipeptidos com actividade do lif
US5506131A (en) 1987-06-05 1996-04-09 The United States Of America As Represented By The Department Of Health And Human Services Immortalized human cell lines containing exogenous cytochrome P450 genes
GB8810400D0 (en) 1988-05-03 1988-06-08 Southern E Analysing polynucleotide sequences
US5002867A (en) 1988-04-25 1991-03-26 Macevicz Stephen C Nucleic acid sequence determination by multiple mixed oligonucleotide probes
WO1990001541A1 (en) 1988-08-04 1990-02-22 Amrad Corporation Limited In vitro propagation of embryonic stem cells
SE463386B (sv) 1989-03-17 1990-11-12 Nilas Tore Nilsson Anordning foer bildvisning
US6040138A (en) 1995-09-15 2000-03-21 Affymetrix, Inc. Expression monitoring by hybridization to high density oligonucleotide arrays
EP0553258A4 (en) 1990-10-17 1993-09-22 Jack D. Love Identification and paternity determination by detecting presence or absence of multiple nucleic acid sequences
US5197985A (en) 1990-11-16 1993-03-30 Caplan Arnold I Method for enhancing the implantation and differentiation of marrow-derived mesenchymal cells
US5486359A (en) 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
WO1992010588A1 (en) 1990-12-06 1992-06-25 Affymax Technologies N.V. Sequencing by hybridization of a target nucleic acid to a matrix of defined oligonucleotides
JPH06319535A (ja) 1991-04-12 1994-11-22 Bio Material Kenkyusho:Kk 株化肝細胞
JPH07501206A (ja) * 1991-08-07 1995-02-09 イェシバ・ユニバーシティ 前駆肝細胞の増殖
US6069005A (en) 1991-08-07 2000-05-30 Albert Einstein College Of Medicine Of Yeshwa University Hapatoblasts and method of isolating same
WO1993017126A1 (en) 1992-02-19 1993-09-02 The Public Health Research Institute Of The City Of New York, Inc. Novel oligonucleotide arrays and their use for sorting, isolating, sequencing, and manipulating nucleic acids
EP1262560A2 (de) 1992-05-29 2002-12-04 Abbott Laboratories Methode zur Herstellung von cDNA ausgehend von einer RNA Zielsequenz in einer Probe
WO1994000484A1 (en) 1992-06-22 1994-01-06 Young Henry E Scar inhibitory factor and use thereof
US5690926A (en) 1992-10-08 1997-11-25 Vanderbilt University Pluripotential embryonic cells and methods of making same
US5453357A (en) 1992-10-08 1995-09-26 Vanderbilt University Pluripotential embryonic stem cells and methods of making same
AU689758B2 (en) 1992-10-09 1998-04-09 Advanced Tissue Sciences, Inc. Liver reserve cells
CA2154265C (en) 1993-01-21 2011-01-04 Spencer B. Farr Methods and diagnostic kits utilizing mammalian stress promoters to determine toxicity of a compound
US6027880A (en) 1995-08-02 2000-02-22 Affymetrix, Inc. Arrays of nucleic acid probes and methods of using the same for detecting cystic fibrosis
US5459037A (en) 1993-11-12 1995-10-17 The Scripps Research Institute Method for simultaneous identification of differentially expressed mRNAs and measurement of relative concentrations
US5773213A (en) 1994-06-06 1998-06-30 Brigham & Women's Hospital Method for conducting sequential nucleic acid hybridization steps
RU2111254C1 (ru) 1994-07-11 1998-05-20 Институт молекулярной биологии им.В.А.Энгельгардта РАН СПОСОБ ДЕТЕКЦИИ ДИФФЕРЕНЦИАЛЬНО ЭКСПРЕССИРУЮЩИХСЯ МАТРИЧНЫХ РНК И КЛОНИРОВАНИЯ СООТВЕТСТВУЮЩИХ ИМ ФРАГМЕНТОВ кДНК
US5914268A (en) 1994-11-21 1999-06-22 National Jewish Center For Immunology & Respiratory Medicine Embryonic cell populations and methods to isolate such populations
US5830645A (en) 1994-12-09 1998-11-03 The Regents Of The University Of California Comparative fluorescence hybridization to nucleic acid arrays
US5843780A (en) 1995-01-20 1998-12-01 Wisconsin Alumni Research Foundation Primate embryonic stem cells
US5736396A (en) 1995-01-24 1998-04-07 Case Western Reserve University Lineage-directed induction of human mesenchymal stem cell differentiation
US5705365A (en) 1995-06-07 1998-01-06 Gen-Probe Incorporated Kits for determining pre-amplification levels of a nucleic acid target sequence from post-amplification levels of product
US5861313A (en) 1995-06-07 1999-01-19 Ontogeny, Inc. Method of isolating bile duct progenitor cells
DE19525285C2 (de) 1995-06-28 1999-04-15 Inst Pflanzengenetik & Kultur In vitro Testverfahren zum Nachweis Chemikalien-induzierter embryotoxischer/teratogener Effekte
WO1997013877A1 (en) * 1995-10-12 1997-04-17 Lynx Therapeutics, Inc. Measurement of gene expression profiles in toxicity determination
US5972693A (en) 1995-10-24 1999-10-26 Curagen Corporation Apparatus for identifying, classifying, or quantifying DNA sequences in a sample without sequencing
US5736332A (en) 1995-11-30 1998-04-07 Mandecki; Wlodek Method of determining the sequence of nucleic acids employing solid-phase particles carrying transponders
US6156502A (en) 1995-12-21 2000-12-05 Beattie; Kenneth Loren Arbitrary sequence oligonucleotide fingerprinting
JP2002515738A (ja) 1996-01-23 2002-05-28 アフィメトリックス，インコーポレイティド 核酸分析法
CA2244891C (en) 1996-02-09 2008-12-30 Cornell Research Foundation, Inc. Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays
DE19606207A1 (de) 1996-02-21 1997-08-28 Univ Duesseldorf H Heine Verfahren zur Bestimmung der Phototoxizität und/oder Photosensibilität von Stoffen oder Stoffgemischen sowie dessen Verwendung
US5811297A (en) 1996-03-07 1998-09-22 Amba Biosciences, Llc Immortalized hematopoietic cell lines, cell system thereof with stromal cells, in vitro, ex vivo and in vivo uses, & in vitro generation of dendritic cells and macrophages
AU3568897A (en) 1996-06-07 1998-01-05 Eos Biotechnology, Inc. Immobilised linear oligonucleotide arrays
WO1997047734A1 (en) 1996-06-14 1997-12-18 The Regents Of The University Of California In vitro derivation and culture of primate pluripotent stem cells and therapeutic uses thereof
US5800690A (en) 1996-07-03 1998-09-01 Caliper Technologies Corporation Variable control of electroosmotic and/or electrophoretic forces within a fluid-containing structure via electrical forces
US5827740A (en) 1996-07-30 1998-10-27 Osiris Therapeutics, Inc. Adipogenic differentiation of human mesenchymal stem cells
WO1998007841A1 (en) 1996-08-19 1998-02-26 University Of Massachusetts Embryonic or stem-like cell lines produced by cross species nuclear transplantation
EP0943012A4 (de) 1996-09-19 2004-06-30 Affymetrix Inc Identifizierung molekularer sequenzsignaturen und relevante verfahren
JPH10179150A (ja) 1996-10-22 1998-07-07 Sumitomo Bakelite Co Ltd 肝細胞培養方法及び薬物代謝能測定方法
US6133436A (en) 1996-11-06 2000-10-17 Sequenom, Inc. Beads bound to a solid support and to nucleic acids
US6060240A (en) 1996-12-13 2000-05-09 Arcaris, Inc. Methods for measuring relative amounts of nucleic acids in a complex mixture and retrieval of specific sequences therefrom
WO1999010535A1 (en) 1997-08-22 1999-03-04 Yale University A process to study changes in gene expression in stem cells
WO1999023254A1 (en) * 1997-10-31 1999-05-14 Affymetrix, Inc. Expression profiles in adult and fetal organs
WO1999027090A1 (en) * 1997-11-20 1999-06-03 Smithkline Beecham Corporation Methods for identifying the toxic/pathologic effect of environmental stimuli on gene transcription
ATE295899T1 (de) 1998-02-23 2005-06-15 Phylonix Pharmaceuticals Inc Screeningverfahren für die aktivität von agenzien unter verwendung von teleosten
ATE347102T1 (de) * 1998-02-25 2006-12-15 Us Health Zellulare anordnungen für schnelle molekulare profilidentifizierung
US20020142976A1 (en) * 1998-04-27 2002-10-03 Icos Corporation Materials and methods for modulating differentiation
US6129911A (en) 1998-07-10 2000-10-10 Rhode Island Hospital, A Lifespan Partner Liver stem cell
US6406921B1 (en) * 1998-07-14 2002-06-18 Zyomyx, Incorporated Protein arrays for high-throughput screening
JP2002525127A (ja) * 1998-09-25 2002-08-13 マサチューセッツ インスティテュート オブ テクノロジー 遺伝子型決定およびｄｎａ分析に関する、方法および生成物
WO2000029002A2 (en) 1998-11-13 2000-05-25 Osiris Therapeutics, Inc. In utero transplantation of human mesenchymal stem cells
CA2353309A1 (en) 1998-12-09 2000-06-15 Vistagen, Inc. Toxicity typing using embryoid bodies
US7456017B2 (en) * 1999-10-01 2008-11-25 University Of North Carolina At Chapel Hill Processes for clonal growth of hepatic progenitor cells
IL149933A0 (en) * 1999-12-06 2002-11-10 Gen Hospital Corp Pancreatic stem cells and their use in transplantation
US6458589B1 (en) 2000-04-27 2002-10-01 Geron Corporation Hepatocyte lineage cells derived from pluripotent stem cells
JP2004503255A (ja) 2000-06-14 2004-02-05 ビスタジェン　インコーポレイテッド 間葉幹細胞を使用する毒性の分類
AU2001268449A1 (en) 2000-06-14 2001-12-24 Vistagen, Inc. Toxicity typing using liver stem cells
EP1904845A4 (de) * 2005-07-07 2009-11-25 David E Kohne Verbesserte proteinexpressionsvergleichstestergebnisse und anwendungen

Also Published As

Publication number Publication date
CA2412361C (en) 2011-08-23
ES2334639T3 (es) 2010-03-15
US8143009B2 (en) 2012-03-27
AU2001268449A1 (en) 2001-12-24
DK1290444T3 (da) 2010-01-18
EP1290444A1 (de) 2003-03-12
JP2004503256A (ja) 2004-02-05
KR100865664B1 (ko) 2008-10-29
US8512957B2 (en) 2013-08-20
US20020012905A1 (en) 2002-01-31
US20120220469A1 (en) 2012-08-30
CA2412361A1 (en) 2001-12-20
KR20030009532A (ko) 2003-01-29
HK1054980A1 (zh) 2003-12-19
US20070111195A1 (en) 2007-05-17
ATE445158T1 (de) 2009-10-15
WO2001096866A1 (en) 2001-12-20
EP1290444B1 (de) 2009-10-07

Similar Documents

Publication Publication Date Title
DE60140120D1 (de) Toxizitätstypisierung unter verwendung von leberstammzellen
DE69942459D1 (de) Isolierte nukleinsäuremoleküle die t-zellen induzierbare faktoren kodieren (tif), kodierte proteine und ihre anwendung
AU6152301A (en) Detection of nucleic acid hybridization by fluorescence polarization
ID26328A (id) Penghambat raf kinase menggunakan urea heterosiklik tersubstitusi aril dan heteroaril
ATE431854T1 (de) Auf bio-barcodes beruhender nachweis von zielanalyten
ATE386815T1 (de) Methoden und syteme zur überwachung intrazellulärer bindereaktionen
HK1152378A1 (en) Labeled cells for use as an internal functional control in rare cell detection assays
DE60322880D1 (de) Einfache katalytische dna-biosensoren für ionen auf grundlage von farbveränderungen
DK1040349T4 (da) Positionering og elektrofysisk karakterisering af individuelle celler og rekonstituerede membransystemer på bærere med mikrostruktur
DE69735445D1 (de) Abspaltbare, nicht-flüchtige moleküle zur massenmarkierung
ATE512233T1 (de) Screeningverfahren für die aktivität von agenzien unter verwendung von teleosten
ATE330038T1 (de) Nukleinsäure-biosensor
DE60235005D1 (de) Nachweis der instabilität von mikrosatelliten und
ATE336591T1 (de) Nachweisverfahren für kurze sequenzvarianten
MX2007012486A (es) Ensayos de investigacion sobre estilbazio.
EA200300880A1 (ru) Способ детекции нуклеотидного полиморфизма
EA200500355A1 (ru) Способ обнаружения, характеристики и мониторинга углеводородных месторождений
ATE541924T1 (de) Selektion und isolierung lebender zellen unter verwendung rna-bindender sonden
BR9703386A (pt) Células aviárias imortalizadas
ATE325190T1 (de) Genetische screeningverfahren
DK0750637T3 (da) CAI resistens, som koder for et protein, samt anvendelse deraf
WO2005089509A3 (en) High throughput assay systems and methods for identifying agents that alter expression of cellular proteins
DK1337849T3 (da) Fremgangsmåder og sammensætninger til at sortere og/eller bestemme mikroorganismer
ATE386140T1 (de) Methoden und reagenzien zur in situ amplifizierung
DE69837397D1 (de) Genetische veränderungen im zusammenhang mit krebs

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: VISTAGEN, INC., SOUTH SAN FRANCISCO, CALIF., US

8364 No opposition during term of opposition